No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study

Adeniran O. R.; Kim H.; Spiotto M. T.; Feldman L.; Hu P.; Chen L.; Nallari A.; Qu J.; Haverkos B.; Rastogi S.; Chilkulwar A.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study

【24h】

No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study

机译：在晚期T期头颈鳞状细胞癌（ATSHNSCC）中比较5-氟尿嘧啶，羟基脲和两次每日放疗（FHX）与大剂量顺铂和放疗（CRT）的结果无差异

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2016年第4期|共1页
作者
Adeniran O. R.; Kim H.; Spiotto M. T.; Feldman L.; Hu P.; Chen L.; Nallari A.; Qu J.; Haverkos B.; Rastogi S.; Chilkulwar A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study [J] . Adeniran O. R., Kim H., Spiotto M. T., International Journal of Radiation Oncology, Biology, Physics . 2016,第4期

机译：在晚期T期头颈鳞状细胞癌（ATSHNSCC）中比较5-氟尿嘧啶，羟基脲和两次每日放疗（FHX）与大剂量顺铂和放疗（CRT）的结果无差异
2. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck. [J] . Katori H, Tsukuda M Clinical oncology . 2005,第3期

机译：多西他赛，顺铂和5-氟尿嘧啶（TPF）诱导放化疗与TPF同步放化疗相比，局部晚期头颈部鳞状细胞癌患者的比较。
3. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: Final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. [J] . Rapidis AD, Trichas M, Stavrinidis E, Oral oncology . 2006,第7期

机译：在头颈部晚期鳞状细胞癌中，诱导化疗后同时进行化学放疗：多西他赛，顺铂和5-氟尿嘧啶的II期研究的最终结果，为期4年。
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. [D] . 野﨑, 結 2019

机译：PD-L1特异性辅助性T细胞表现出有效的抗肿瘤反应：针对头颈部鳞状细胞癌中PD-L1的癌症免疫疗法的新策略。
6. Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC) [O] . Muhammad Furqan, Travis P. Snyders, Mohammed U. Saqlain, 2019

机译：将大剂量顺铂与基于顺铂的联合化疗在局部晚期头颈部鳞状细胞癌（LAHNSCC）的确定性同时放化疗中进行比较
7. No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study [O] . O.R. Adeniran, H. Kim, M.T. Spiotto, 2016

机译：结果对比较5-氟尿嘧啶，羟基脲和两次的每日放射治疗（FHX）对高剂量顺铂和放射治疗（CRT）的差异，在先进的T阶段头部和颈部鳞状细胞癌（ATSHNSCC）：回顾性研究

No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study

著录项

引文网络

相似文献

相关主题

期刊订阅